Clinical Trial

Disease Activity Biomarkers in Patients With Systemic Lupus Erythematosus

Study acronym: JD001
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 5, 2022 (before its estimated December 31, 2022 completion). Its status may not reflect the trial's current state.
Summary
The aim of this research project is to better understand the origin and clinical significance of two lupus-specific "genetic signatures" (IFN signature and plasma cell signature) in patient subgroups with well-defined clinical characteristics. Our aim is to correlate these genetic signatures with cell activation profiles and the production of specific cytokines in different populations from whole blood and in short-term cultures of these circulating cells.
Trial Details
NCT Number NCT05443516
Lead Sponsor Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions Lupus Nephritis
Enrollment 250 participants
Start Date 2014-06-16
Primary Completion 2022-12-31 (estimated)
Study Completion 2032-12-31 (estimated)
Updated on ClinicalTrials.gov 2022-07-05